Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adenosine Blockage in Tumor Microenvironment and Improvement of Cancer Immunotherapy
Samaneh Arab, Jamshid Hadjati
Immune Network (2019) Vol. 19, Iss. 4
Open Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy
Vincenzo Salemme, Giorgia Centonze, Federica Cavallo, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 183
Immune checkpoint molecules in natural killer cells as potential targets for cancer immunotherapy
Yuqing Cao, Xiaoyu Wang, Tianqiang Jin, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 121
CAR-T Cells in the Treatment of Ovarian Cancer: A Promising Cell Therapy
Xiwen Zhang, Yishi Wu, Tianmin Xu, et al.
Biomolecules (2023) Vol. 13, Iss. 3, pp. 465-465
Open Access | Times Cited: 33
Ectonucleotidase CD73 and CD39 expression in non-small cell lung cancer relates to hypoxia and immunosuppressive pathways
Alexandra Giatromanolaki, Maria Kouroupi, Stamatia Pouliliou, et al.
Life Sciences (2020) Vol. 259, pp. 118389-118389
Closed Access | Times Cited: 48
Metabolic alterations in the tumor microenvironment and their role in oncogenesis
Lihie Eisenberg, Michal Eisenberg‐Bord, Avital Eisenberg‐Lerner, et al.
Cancer Letters (2020) Vol. 484, pp. 65-71
Closed Access | Times Cited: 42
Emerging Therapeutics for Patients with Triple-Negative Breast Cancer
Elisa Agostinetto, Daniel Eiger, Kevin Punie, et al.
Current Oncology Reports (2021) Vol. 23, Iss. 5
Closed Access | Times Cited: 38
Extracellular ATP and adenosine in tumor microenvironment: Roles in epithelial–mesenchymal transition, cell migration, and invasion
Cora Lilia Alvarez, María F. Troncoso, María V. Espelt
Journal of Cellular Physiology (2021) Vol. 237, Iss. 1, pp. 389-400
Closed Access | Times Cited: 33
Tumor microenvironment, immune response and post-radiotherapy tumor clearance
Michael I. Koukourakis, Alexandra Giatromanolaki
Clinical & Translational Oncology (2020) Vol. 22, Iss. 12, pp. 2196-2205
Closed Access | Times Cited: 33
Research Progress on Therapeutic Targeting of Cancer-Associated Fibroblasts to Tackle Treatment-Resistant NSCLC
Chenxin Li, Yusong Qiu, Yong Zhang
Pharmaceuticals (2022) Vol. 15, Iss. 11, pp. 1411-1411
Open Access | Times Cited: 19
Improving combination therapies: targeting A2B-adenosine receptor to modulate metabolic tumor microenvironment and immunosuppression
Jason V. Evans, Shankar Suman, Mounika Goruganthu, et al.
JNCI Journal of the National Cancer Institute (2023) Vol. 115, Iss. 11, pp. 1404-1419
Open Access | Times Cited: 11
Nucleotide metabolism in the regulation of tumor microenvironment and immune cell function
Helena Borland Madsen, Marlies J. W. Peeters, Per thor Straten, et al.
Current Opinion in Biotechnology (2023) Vol. 84, pp. 103008-103008
Open Access | Times Cited: 11
Nanoparticles targeting the adenosine pathway for cancer immunotherapy
Kehua Jiang, Jian Wu, Qing Wang, et al.
Journal of Materials Chemistry B (2024) Vol. 12, Iss. 24, pp. 5787-5811
Closed Access | Times Cited: 4
CD73 Molecule Inhibitor Upregulates miR16 Expression in Experimental Glioblastoma and Inhibits Angiogenesis by Targeting VEGF
Samaneh Arab, Sahar Ghasemi, Marjan Bahraminasab, et al.
Journal of Molecular Neuroscience (2025) Vol. 75, Iss. 2
Open Access
CD73 Overexpression Promotes Progression and Recurrence of Papillary Thyroid Carcinoma
Young Mun Jeong, Hae Jin Cho, Tae‐Min Kim, et al.
Cancers (2020) Vol. 12, Iss. 10, pp. 3042-3042
Open Access | Times Cited: 29
Pharmacological inhibition of hematopoietic progenitor kinase 1 positively regulates T-cell function
Yun Wang, Kelvin Zhang, Peter Georgiev, et al.
PLoS ONE (2020) Vol. 15, Iss. 12, pp. e0243145-e0243145
Open Access | Times Cited: 28
Metabolic Reprogramming in the Tumor Microenvironment With Immunocytes and Immune Checkpoints
Yaolin Xu, Lijie He, Qiang Fu, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 24
Adenosine Targeting as a New Strategy to Decrease Glioblastoma Aggressiveness
Valentina Bova, Alessia Filippone, Giovanna Casili, et al.
Cancers (2022) Vol. 14, Iss. 16, pp. 4032-4032
Open Access | Times Cited: 17
Adenosine Signaling in the Tumor Microenvironment
Luca Antonioli, Matteo Fornai, Carolina Pellegrini, et al.
Advances in experimental medicine and biology (2020), pp. 145-167
Closed Access | Times Cited: 25
The Emerging World of Membrane Vesicles: Functional Relevance, Theranostic Avenues and Tools for Investigating Membrane Function
Aswin T. Srivatsav, Shobhna Kapoor
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 23
Serum Metabolite Biomarkers Predictive of Response to PD-1 Blockade Therapy in Non-Small Cell Lung Cancer
Xiaoqun Nie, Liliang Xia, Fang Gao, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 23
Mild and large-scale synthesis of nanoscale metal-organic framework used as a potential adenine-based drug nanocarrier
Trang Nguyen, Linh Hồ Thùy Nguyễn, Ngoc Xuan Dat, et al.
Journal of Drug Delivery Science and Technology (2020) Vol. 61, pp. 102135-102135
Closed Access | Times Cited: 23
The Great War of Today: Modifications of CAR-T Cells to Effectively Combat Malignancies
Andriy Zhylko, Magdalena Winiarska, Agnieszka Graczyk‐Jarzynka
Cancers (2020) Vol. 12, Iss. 8, pp. 2030-2030
Open Access | Times Cited: 21
Innovative CAR-T Cell Therapy for Solid Tumor; Current Duel between CAR-T Spear and Tumor Shield
Yuna Jo, Laraib Amir Ali, Ju A Shim, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2087-2087
Open Access | Times Cited: 21
Immune-Inhibitory Gene Expression is Positively Correlated with Overall Immune Activity and Predicts Increased Survival Probability of Cervical and Head and Neck Cancer Patients
Megha Budhwani, Gavin Turrell, Meihua Yu, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 20
Adenosinergic Signaling as a Key Modulator of the Glioma Microenvironment and Reactive Astrocytes
Gabriela Nogueira Debom, Dominique S. Rubenich, Elizandra Braganhol
Frontiers in Neuroscience (2022) Vol. 15
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top